Cargando…

“Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()

Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that a...

Descripción completa

Detalles Bibliográficos
Autor principal: Medina-Kauwe, L.K.
Formato: Texto
Lenguaje:English
Publicado: Elsevier B.V. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040389/
https://www.ncbi.nlm.nih.gov/pubmed/17707545
http://dx.doi.org/10.1016/j.addr.2007.06.009
_version_ 1782137088438697984
author Medina-Kauwe, L.K.
author_facet Medina-Kauwe, L.K.
author_sort Medina-Kauwe, L.K.
collection PubMed
description Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that are known to facilitate entry of pathogens and potential delivery agents. Recent characterization of the trafficking mechanisms of prion proteins and certain bacteria may present new paradigms for strategizing improvements in therapeutic spread and retention of therapy. This review will provide an overview of such endocytic pathways, and discuss current and future possibilities in using these routes as a means to improve therapeutic delivery.
format Text
id pubmed-2040389
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-20403892007-10-23 “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?() Medina-Kauwe, L.K. Adv Drug Deliv Rev Article Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that are known to facilitate entry of pathogens and potential delivery agents. Recent characterization of the trafficking mechanisms of prion proteins and certain bacteria may present new paradigms for strategizing improvements in therapeutic spread and retention of therapy. This review will provide an overview of such endocytic pathways, and discuss current and future possibilities in using these routes as a means to improve therapeutic delivery. Elsevier B.V. 2007-08-10 2007-07-05 /pmc/articles/PMC2040389/ /pubmed/17707545 http://dx.doi.org/10.1016/j.addr.2007.06.009 Text en Copyright © 2007 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Medina-Kauwe, L.K.
“Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()
title “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()
title_full “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()
title_fullStr “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()
title_full_unstemmed “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()
title_short “Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?()
title_sort “alternative” endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040389/
https://www.ncbi.nlm.nih.gov/pubmed/17707545
http://dx.doi.org/10.1016/j.addr.2007.06.009
work_keys_str_mv AT medinakauwelk alternativeendocyticmechanismsexploitedbypathogensnewavenuesfortherapeuticdelivery